Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating all-trans-retinoic acid (tretinoin), bevacizumab, and atezolizumab in colorectal cancer. The study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)
  • Bevacizumab (bevacizumab)
  • TRETINOIN (TRETINOIN)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING